Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Guergana Petrova (Sofia, Bulgaria), Guergana Petrova, Penka Perenovska, Tanya Strateva. Could nan1-expression and production by pseudomonas aeruginosa be a prognostic factor for survival in CF patients. Eur Respir J 2016; 48: Suppl. 60, 4862

Member's Comments

No comment yet.

Related content which might interest you: Pseudomonas aeruginosa isolates in bronchiectasis: Wath particulaties and risk factors? Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Pseudomonas aeruginosa colonisation in patients without bronchiectasis Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 LATE-BREAKING ABSTRACT: Pseudomonas aeruginosa strain prevalence, adaptation and diversification, during chronic lung infections of UK non-cystic fibrosis bronchiectasis patients Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 Risk factors and outcomes of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa: a clinical case-control study Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Respiratory commensal streptococcus spp do not modulate the outcome of pseudomonas aeruginosa infection in vivo Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Prevalence of pseudomonas aeruginosa in pancreatic sufficient CF patients in Scandinavia Source: Eur Respir J 2006; 28: Suppl. 50, 714s Year: 2006 Epidemiology, treatment and outcomes of nosocomial pneumonia due to Gram-negative bacteria Source: Eur Respir J 2007; 30: Suppl. 51, 408s Year: 2007 Bacteremic vs. non-bacteremic pneumococcal pneumonia in immunocompetent patients: Predictive and prognostic factors Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Isolation of stenotrophomonas maltophilia in lung transplant recipients: effects of treatment on prevalence and outcome Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 A comprehensive analysis of the impact of pseudomonas aeruginosa colonisation in adult bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Genotypic studies of pseudomonas aeruginosa isolates from adult non-cystic fibrosis bronchiectasis patients Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015 Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients Source: Eur Respir J, 52 (2) 1701190; 10.1183/13993003.01190-2017 Year: 2018 Pseudomonas aeruginosa from CF airways uses various strategies to outcompete staphylococcus aureus Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 Early mortality in patients with community-acquired pneumonia: causes and risk factors Source: Eur Respir J 2008; 32: 733-739 Year: 2008 The role of the type 3 secretion system effector protein ExoY during pathogenesis of pseudomonas aeruginosa lung infections Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014 Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Predictive factors for true bacteremia and clinical utility of blood cultures as a prognostic tool in patients with community-onset pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia pneumonia: 10 years experience of single center Source: International Congress 2019 – Airway infection in COPD Year: 2019 Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD. Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020